🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day British shipping. Vendors market the drug there before redirecting customers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.

Several experts stated the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to TikTok, the platform has removed violative content and banned associated keywords and search suggestions. The organization said it was committed to keeping the service safe and investing in strengthening compliance measures.

Digital Marketplace Operations

Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at residence.

Within minutes of entering one group, a seller posted WhatsApp details, where most purchases take place. The seller provided an guidebook and promised delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Inside these groups, messages show dark colored parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may subject users to possibly significant health risks”.